Upfront or intermediate treatment of advanced ovarian cancer patients with cytoreduction plus HIPEC: Results of a retrospective study
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.26280
Abstract: Newly diagnosed advanced‐stage ovarian cancer patients are treated with neoadjuvant chemotherapy, primary or intermediate cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy (HIPEC). The aim of this study is to evaluate the optimal timing of cytoreduction plus… read more here.
Keywords: plus hipec; cancer patients; ovarian cancer; advanced ovarian ... See more keywords
EP949 Cytoreduction plus HIPEC in advanced ovarian cancer: 10-year experience of the naval and veterans hospital of athens
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Gynecological Cancer"
DOI: 10.1136/ijgc-2019-esgo.995
Abstract: Introduction/Background Ovarian cancer is the most common cause of gynecological malignancy mortality in the western world. Hyperthermic intraperitoneal chemotherapy (HIPEC) is a method of locoregional treatment that has recently been applied to selected patients. The… read more here.
Keywords: ovarian cancer; plus hipec; cancer; year experience ... See more keywords